[DOI] [PMC free article] [PubMed] [Google Scholar] 2.Vetvik K.G., MacGregor E.A
doi: 10.1177/44.8.8756753 18 SchonhoffSBaggioLRatineauCRaySKLindnerJMagnusonMAet al
He completed his residency in internal medicine and a rigorous fellowship in gastroenterology and liver disease at the Stony Brook University Hospital
Understanding these differences matters if you are transitioning between compounds or considering alternatives
General eligibility criteria per brand disclosure include BMI 30, or BMI 27 with at least one qualifying comorbidity
Both GLP-1s and GIPs are tied to plenty of other compelling health benefits outside of weight loss, including diabetes management, reduced heart disease risk, and, potentially, dementia prevention